Target intelligence / Profile preview

Gastrointestinal mucosal surface topography

Molecular classification
Other
01

Overview

Gastrointestinal mucosal surface topography refers to the complex three-dimensional structural organization of the innermost lining of the digestive tract. This architecture includes macro-scale features like plicae circulares and micro-scale structures such as villi and microvilli, which collectively serve to maximize the surface area available for nutrient absorption and provide a critical physical barrier against pathogens (Source: NIH StatPearls). This morphological arrangement is essential for maintaining the intestinal barrier and facilitating the efficient transport of electrolytes and nutrients. In various pathological states, such as Celiac disease or tropical sprue, this topography is severely altered through villous atrophy and crypt hyperplasia, leading to significant malabsorption (Source: Mayo Clinic). While it is not a molecular target in the traditional pharmacological sense, the preservation or restoration of mucosal architecture is a primary clinical endpoint in treating inflammatory and autoimmune gastrointestinal disorders. Drugs do not bind to the topography itself; instead, they target underlying molecular drivers of inflammation—such as TNF-alpha or specific integrins—to prevent the tissue damage that leads to topographical degradation (Source: PubMed, PMID: 30214800). Consequently, the assessment of mucosal topography remains a gold standard for diagnosing disease severity and monitoring the efficacy of therapeutic interventions.

Other names
Gastrointestinal mucosal architectureIntestinal mucosal morphologyVillous-crypt architectureMucosal relief
02

Mechanism of action

Not applicable; this is a morphological and anatomical feature of tissue rather than a specific molecular target such as a receptor or enzyme.

03

Biological functions

Nutrient absorptionPhysical barrier functionSurface area expansionImmune surveillance
04

Disease associations

Celiac diseaseInflammatory bowel diseaseAtrophic gastritisTropical sprueDrug-induced enteropathy
05

Safety considerations

Drug-induced villous atrophy (e.g., from ARBs like olmesartan)Mucosal erosionLoss of absorptive surface areaIncreased intestinal permeability
06

Biomarkers

Villous height-to-crypt depth ratioMarsh classification scoreIntestinal villi blunting

Beyond the preview

Go deeper on Gastrointestinal mucosal surface topography.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastrointestinal mucosal surface topography.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call